In Europe, a study randomly assessed 3,250 patients with DM from 31 centers in 16 European countries and suggested that the overall prevalence of DPN is 28% without significant geographical differences (the EURODIAB IDDM Complications Study) (35)
Previous studies suggest that agonism of the cannabinoid receptors, by either endocannabinoids or exogenous cannabinoids, acutely stimulates food craving, intake, and reward, and promotes the storage of energy in adipose tissues, whereas antagonism of the cannabinoid receptors reduces food intake and body weight 15,16,17,18,19
Compounded Tirzepatide Compounded tirzepatide is not FDA-approved for safety, effectiveness, or quality
2 This helps lower glucose without the increased risk of hypoglycemia seen with other antidiabetic medications